Mallinckrodt plc and Endo, Inc. (NDOI) have secured the necessary shareholder approvals to proceed with their merger, a stock-and-cash transaction aimed at forming a global, diversified pharmaceutical leader.
With this approval, Mallinckrodt will now seek confirmation of the scheme of arrangement from the Irish High Court, with a sanction hearing expected in July. Subject to court approval and other closing conditions, the companies aim to finalise the merger shortly after the hearing. The combined entity will have its global headquarters in Dublin, Ireland.
Friday NDOI closed at $20.9 or 1.65% lower on the OTC Markets OTCQX.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.